Human Immunodeficiency Virus (HIV) and AIDS Vocabulary

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/19

flashcard set

Earn XP

Description and Tags

Flashcards covering key definitions, viral enzymes, life cycle stages, clinical manifestations, diagnosis criteria, and treatment modalities for HIV and AIDS.

Last updated 12:58 PM on 8/30/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

20 Terms

1
New cards

HIV

Human Immunodeficiency Virus; a retrovirus that targets and destroys CD4+ T cells, leading to immune system collapse if left untreated.

2
New cards

AIDS

Acquired Immune Deficiency Syndrome; severe immune system dysfunction caused by HIV, diagnosed when CD4+ cell count drops below 200cells/mm3200\,\text{cells/mm}^3 or an AIDS-defining condition is present.

3
New cards

HIV-1

The first discovered and most prevalent strain of the Human Immunodeficiency Virus worldwide.

4
New cards

HIV-2

A less pathogenic strain of the Human Immunodeficiency Virus that is largely confined to West Africa.

5
New cards

Retrovirus

A type of virus that utilizes the enzyme reverse transcriptase to translate its RNA genetic material into DNA.

6
New cards

Reverse transcriptase

A viral enzyme that makes a DNA copy from the HIV viral RNA genetic material.

7
New cards

HIV integrase

A viral enzyme that assists in inserting the viral DNA copy into the genetic material of the host cell.

8
New cards

HIV protease

A viral enzyme responsible for the final stages of virus production, assembling virus particles to be released to attack new cells.

9
New cards

Seven stages of HIV life cycle

The step-by-step process of viral replication: 1. Binding, 2. Fusion, 3. Reverse transcription, 4. Integration, 5. Replication, 6. Assembly, and 7. Budding.

10
New cards

Seroconversion

The phase in early HIV infection when anti-HIV antibodies become detectable in the blood, typically accompanied by flu-like symptoms for several weeks.

11
New cards

Stage 1: Early infection (Acute)

Initial stage characterized by rapid viral replication, lack of detection by traditional lab tests, absence of symptoms initially, followed by seroconversion.

12
New cards

Stage 2: Clinical latency (Chronic)

Stage where viral levels stabilize; lasts 3 to 12 years without treatment (or decades with treatment) and is generally asymptomatic or mild in symptoms.

13
New cards

Stage 3: Symptomatic HIV infection

Advanced stage marked by a persistent drop in CD4+ T cell count, increased viral load, ineffective immune defense, and progression to AIDS.

14
New cards

AIDS-defining conditions

Specific opportunistic illnesses or neoplasms (e.g., Kaposi's Sarcoma, Wasting Syndrome, Pneumocystis Jiroveci Pneumonia, pervasive candidiasis) required for an AIDS diagnosis.

15
New cards

HIV-associated dementia

Also known as AIDS dementia complex; a cognitive dysfunction causing memory loss, mental slowness, behavioral changes, word-finding difficulty, and motor/speech/balance problems.

16
New cards

Percutaneous needle-stick injury

An occupational blood exposure route for healthcare workers that carries an HIV transmission risk of less than 1%1\%.

17
New cards

Antiretroviral therapy (ART)

Pharmacological treatment for HIV aimed at reducing viral load to undetectable levels, most commonly consisting of dual nucleosides plus a third agent.

18
New cards

NRTIs

Nucleoside Reverse Transcriptase Inhibitors; an ART drug class that inhibits reverse transcriptase to block viral RNA incorporation into host DNA, carrying a black box warning for lactic acidosis syndrome.

19
New cards

PrEP (Pre-exposure prophylaxis)

The use of antiretroviral medications prior to potential exposure, combined with condom use, which can lower HIV transmission risk by greater than 90%90\%.

20
New cards

PEP (Post-exposure prophylaxis)

Emergency treatment consisting of ART taken for 28 days following potential exposure, accompanied by HIV testing initially and at 6 and 12 weeks.